A peer-reviewed study recently published in the Review of Industrial Organization examines whether removing the right to sue (“delitigation”) affects product safety. The findings highlight the importance of litigation in maintaining vaccine safety.
The study, “Is ‘delitigation’ associated with a change in product safety? The case of vaccines”, by economist Dr. Gayle DeLong at Baruch College in New York, compares vaccines licensed before the passage of the National Childhood Vaccine Injury Act (NCVIA) in 1986 with vaccines licensed after the legislation. Results suggest that vaccine safety deteriorated after consumers were no longer able to sue vaccine makers.
The study examines adverse events (AE) per 100,000 vaccine recipients and finds the AE ratio increased from 21.0 for vaccines licensed before 1986 to 30.8 for vaccines licensed after the legislation. Further investigation reveals that the legislation is associated with an increase of between 9.4 and 12.8 injuries per 100,000 vaccine recipients (see Table 5 below). Serious AEs such as long-term disability or death also increased by about one per 100,000 vaccine recipients.
ARTICLE CONTINUES HERE: https://worldmercuryproject.org/news/liability-protection-lead-unsafe-vaccines/